Mayo Clinic, Hibiscus BioVentures and Innoforce Pharma have launched Mayflower BioVentures, a cell and gene therapy accelerator dedicated to identifying and forming companies around technologies that address unmet patient needs. This academic and industry relationship will establish independent cell and gene therapy companies to advance the development of Mayo Clinic technologies through preclinical and early feasibility studies. With a shared interest in identifying treatments and preventing...